AccuStem Sciences, Inc. (ACUT)

Market Cap	4.16M
Revenue (ttm)	n/a
Net Income (ttm)	-1.38M
Shares Out	11.35M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	352
Average Volume	12,647
Open	0.367
Previous Close	n/a
Day's Range	0.367 - 0.474
52-Week Range	0.271 - 0.987
Beta	3.03
RSI	49.23
Earnings Date	Feb 14, 2025

About AccuStem Sciences

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUT